Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Read more

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Read more

Complete Spinal Cord Injury

We are developing an innovative treatment that aims to improve the patients’ quality of life.

Read more

Press releases

• July 10, 2018BioArctic receives regulatory approval in Finland for a clinical study in patients with Complete Spinal Cord Injury
• July 10, 2018BioArctic Announces Acceptance of BAN2401 Phase 2b Results for Oral Presentation at the AAIC 2018
• July 6, 2018BioArctic announces positive topline results of BAN2401 Phase 2b at 18 months in early Alzheimer’s Disease

Archive

Interim Report January – March 2018

BioArctic AB published the company’s Interim Report January – March 2018 on Thursday, April 26.

• Report
• Presentation
• Webcast

Read the report

Calendar

• August 23, 2018Interim Report January – June 2018
• November 8, 2018Interim Report January – September 2018

All events